PDL BioPharma Reports 2019 Third Quarter Financial Results
INCLINE VILLAGE, Nev., Nov. 6, 2019 |PRNewswire| -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and nine months ended September 30, 2019: Third Quarter Financial Highlights Total revenues were $44.2 million, including $20.3 million…
PDL BioPharma Reports 2019 Third Quarter Financial Results
INCLINE VILLAGE, Nev., Nov. 6, 2019 |PRNewswire| -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and nine months ended September 30, 2019: Third Quarter Financial Highlights Total revenues were $44.2 million, including $20.3 million…